A clinically grounded guide to how medical cannabis may support anxiety management, including eligibility, the evidence base, your patient rights, and how to access a specialist prescription.
Anxiety is a persistent feeling of worry, fear, or unease that significantly interferes with daily life. In the UK, anxiety disorders, including generalised anxiety disorder (GAD), social anxiety disorder, panic disorder, and PTSD-related anxiety, affect approximately 8 million people at any given time.
Conventional first-line treatments include CBT and SSRI medications. However, a meaningful proportion of patients do not achieve adequate symptom relief from these approaches, even after trying multiple treatment cycles.
Generalised Anxiety Disorder can develop due to a combination of biological, psychological, and environmental factors. While the exact cause is not always clear, research suggests that multiple influences may contribute to the development of the condition.
Common contributing factors may include:
Understanding the underlying causes can help guide treatment approaches and improve long-term symptom management.
In the UK, treatment for Generalised Anxiety Disorder often begins with psychological therapies, stress-management techniques, and lifestyle adjustments designed to help manage anxiety and improve coping strategies.
For individuals whose anxiety remains difficult to manage through standard treatments, medical cannabis may offer an alternative pathway under specialist supervision. At LeafEase, patients can access a structured care approach designed to assess eligibility and support safe, clinically guided symptom management throughout their treatment journey.
Yes. Medical cannabis can be legally prescribed in the UK for anxiety by a specialist clinician where conventional treatments have not provided sufficient relief. It became legally prescribable in November 2018, when the UK Government rescheduled cannabis-based products for medicinal use (CBPMs) to allow specialist doctors to prescribe them.
No GP referral is required to access a specialist consultation at LeafEase. Our GMC-registered specialist clinicians will assess your suitability based on your full medical history, previous treatment history, and current symptoms all in a confidential online consultation.
Medical cannabis interacts with the body’s endocannabinoid system, which plays a role in regulating mood, stress responses, sleep, and pain perception. Certain cannabinoids may influence how the body processes emotional stress and physical discomfort.
The evidence base for cannabinoids in anxiety is growing, though it remains developing relative to more established treatments. Here is what the current research shows
Shannon, S. et al. (2019). Cannabidiol in Anxiety and Sleep: A Large Case Series. The Permanente Journal, 23:18–041.
UK observational evidence: A 2020 observational study of UK medical cannabis patients found anxiety to be one of the most commonly treated conditions, with the majority of patients reporting improvement in symptoms.
Erridge, S. et al. (2020). Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review. BMC Psychiatry.
NICE position: NICE acknowledges the limited but emerging evidence base and supports specialist prescribing of cannabis-based products where clinically appropriate on a patient-by-patient basis.
NICE (2019). Cannabis-based medicinal products [NG144]. National Institute for Health and Care Excellence.
of patients saw reduced anxiety scores in one month (Shannon et al., 2019)
people in the UK are affected by an anxiety disorder at any given time.
Source: MIND 2023
Year UK law changed to allow specialist prescribing of medical cannabis
This is one of the most common questions our patients ask.
The key differences are:
CBD oil is an over-the-counter food supplement containing cannabidiol (CBD) only. It is not regulated as a medicine, and its contents and concentration are not subject to the same quality controls as prescription medicines. It is not the same as a medical cannabis prescription.
Medical cannabis is a prescribed, regulated medicine dispensed under a specialist’s direct clinical supervision. It may contain both THC and CBD in clinically determined ratios, and is typically significantly more potent than CBD supplements. It is only available via a valid prescription from a licensed specialist clinic.
For patients with moderate-to-severe anxiety who have not responded adequately to conventional treatments or over-the-counter CBD, prescribed medical cannabis is a clinically distinct and more carefully managed therapeutic option.
A 2019 case series found that CBD reduced anxiety scores in 79% of patients within the first month of treatment, with effects maintained at three months.
Your initial consultation is with a GMC-registered specialist clinician who will review your medical history, previous treatments, and current symptoms. Consultations are conducted online at a time that suits you.
If medical cannabis is appropriate for you, your clinician will determine the right formulation and starting dose. They will explain how to use your medication safely and what to expect.
Your prescription is dispatched discreetly to your home address in clearly labelled original packaging with your prescription details attached.
LeafEase provides regular follow-up appointments to review how you are responding to treatment. Your prescription can be adjusted as needed.
Like any treatment, medical cannabis may cause side effects in some individuals. These effects are typically mild and can vary depending on dosage, treatment type, and individual tolerance.
Possible side effects may include:
Specialist doctors carefully monitor treatment to ensure that medications are used safely and appropriately.
As a medical cannabis patient in the UK,
You have specific legal rights that are important to know:
You can use your prescribed medication typically via a dry herb vaporiser in public spaces such as parks, streets, and open areas. In private venues, staff may ask you to use a designated area. For large events, contact the venue in advance.
You are legally entitled to take your medication at work as directed by your doctor. Speak to your employer in advance if your role involves driving, operating machinery, or if your contract references controlled substances.
You must not drive if impaired. If your prescription contains THC, you may test above the legal roadside limit — but you can use the medical defence under Section 5A(3) of the Road Traffic Act 1988 if you are not impaired and are taking your medication as prescribed.
You are legally permitted to use your prescription medication in your rented home. This is not affected by clauses prohibiting smoking.
Contact the UK embassy for your destination country well in advance of travel. Bring your prescription, prescription-labelled medication tub, and personal ID. Request a travel letter from your clinician.
Medical cannabis refers to cannabis-based products that are prescribed by a specialist doctor for certain medical conditions. These products are tightly regulated and legally available in the UK under specific circumstances.
You may be eligible if:
Medical cannabis may be considered for a range of conditions, including:
Tourette’s syndrome
Each case is assessed individually, based on clinical need and treatment history.
Yes, since November 2018, certain cannabis-based products for medical use (CBPMs) have been legal in the UK when prescribed by a specialist doctor on the General Medical Council Specialist Register.
No referral is required to book an initial consultation with us. However, having access to your medical history and treatment records can support the prescribing process.
During your consultation, a specialist will:
If appropriate, create a treatment plan that the specialist will discuss during an MDT meeting afterwards
Prescriptions may include:
The form and dosage will be tailored to your needs.
Find out if medical cannabis may be right for you — no GP referral needed.
1. Shannon, S., Lewis, N., Lee, H. & Hughes, S. (2019). Cannabidiol in Anxiety and Sleep: A Large Case Series. The Permanente Journal, 23:18–041. doi:10.7812/TPP/18-041
2. Sarris, J., Sinclair, J., Karamacoska, D., Davidson, M. & Firth, J. (2020). Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review. BMC Psychiatry, 20(1), 24. doi:10.1186/s12888-019-2409-8
3. NICE (2019). Cannabis-based medicinal products [NG144]. National Institute for Health and Care Excellence. nice.org.uk/guidance/ng144
4. MIND (2023). Anxiety and panic attacks. mind.org.uk
5. Misuse of Drugs Act 1971; Misuse of Drugs Regulations 2001 (as amended 2018).
6. Road Traffic Act 1988, Section 5A(3) – medical defence for prescribed controlled drugs.
